公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2012 | Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3 | Tai W.-T.; ANN-LII CHENG ; Shiau C.-W.; Liu C.-Y.; Ko C.-H.; Lin M.-W.; PEI-JER CHEN ; Chen K.-F. | Molecular Cancer Therapeutics | 112 | 108 | |
2012 | Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3 | Chen K.-F.; Chen H.-L.; Liu C.-Y.; Tai W.-T.; Ichikawa K.; PEI-JER CHEN ; ANN-LII CHENG | Biochemical Pharmacology | 40 | 35 | |
2004 | Doxorubicin activates hepatitis B virus (HBV) replication in HBV-harboring hepatoblastoma cells. A possible novel mechanism of HBV reactivation in HBV carriers receiving systemic chemotherapy | CHIH-HUNG HSU ; Hsu H.-C.; Chen H.-L.; Gao M.; Yeh P.-Y.; PEI-JER CHEN ; ANN-LII CHENG | Anticancer Research | 47 | 41 | |
2014 | The driving circuit of HBx and androgen receptor in HBV-related hepatocarcinogenesis | Wang S.-H.; Shiou-Hwei Yeh ; PEI-JER CHEN | Gut | 13 | 13 | |
2021 | Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan | CHUN-MING HONG ; Lin, You-Yu; CHUN-JEN LIU ; Lai, Ya-Yun; Shiou-Hwei Yeh ; HUNG-CHIH YANG ; JIA-HORNG KAO ; SHIH-JER HSU ; Huang, Yi-Hsiang; Yang, Sheng-Shun; Kuo, Hsing-Tao; Cheng, Pin-Nan; Yu, Ming-Lung; PEI-JER CHEN | Viruses | 5 | 2 | |
2009 | Dual chronic hepatitis B virus and hepatitis C virus infection | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN | Hepatology International | 43 | 37 | |
2003 | Dynamics of plasma hepatitis B virus levels after highly active antiretroviral therapy in patients with HIV infection | CHI-TAI FANG ; PEI-JER CHEN ; Chen M.-Y.; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG ; Chang A.-L.; DING-SHINN CHEN | Journal of Hepatology | 14 | 11 | |
2019 | Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 10 | 9 | |
2007 | Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan | Hsu C.-S.; CHUN-JEN LIU ; Lai M.-Y.; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | Intervirology | 17 | 16 | |
2010 | Eastern asian expert panel opinion: Designing clinical trials of molecular targeted therapy for hepatocellular carcinoma | Yeo W.; PEI-JER CHEN ; Furuse J.; Han K.-H.; CHIUN HSU ; Lim H.-Y.; Moon H.; Qin S.; Yeoh E.-M.; Ye S.-L. | BMC Cancer | 4 | 4 | |
2007 | Ectopic liver with hepatocellular carcinoma in the peritoneum. | KAO-LANG LIU ; MING-CHIH HO ; PEI-JER CHEN | AJR. American journal of roentgenology | 6 | 7 | |
2011 | Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy | TAI-CHUNG TSENG ; Yu M.-L.; CHUN-JEN LIU ; Lin C.-L.; Huang Y.-W.; Hsu C.-S.; CHEN-HUA LIU ; Kuo S.F.-T.; Pan C.J.-H.; Yang S.-S.; Su C.-W.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 76 | 70 | |
2013 | Effect of Parenteral Selenium Supplementation in Critically Ill Patients: A Systematic Review and Meta-Analysis | Huang T.-S.; Shyu Y.-C.; Chen H.-Y.; Lin L.-M.; Lo C.-Y.; Yuan S.-S.; PEI-JER CHEN | PLoS ONE | 96 | 97 | |
2011 | Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: Genotype B vs C | CHUN-JEN LIU ; Cheng H.-R.; Chen C.-L.; Chen T.-C.; TAI-CHUNG TSENG ; Wang Z.-L.; PEI-JER CHEN ; CHEN-HUA LIU ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Viral Hepatitis | 20 | 19 | |
2019 | Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions | Yu M.-L.; Hung C.-H.; Huang Y.-H.; Peng C.-Y.; Lin C.-Y.; Cheng P.-N.; Chien R.-N.; SHIH-JER HSU ; CHEN-HUA LIU ; Huang C.-F.; Su C.-W.; Huang J.-F.; CHUN-JEN LIU ; JIA-HORNG KAO ; Chuang W.-L.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of the Formosan Medical Association | 10 | 8 | |
2010 | Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma | CHIH-HUNG HSU ; Yang T.-S.; CHIUN HSU ; Toh H.C.; Epstein R.J.; Hsiao L.-T.; PEI-JER CHEN ; ZHONG-ZHE LIN ; Chao T.-Y.; ANN-LII CHENG | British Journal of Cancer | 114 | 112 | |
2000 | Efficacy of consensus interferon in the treatment of chronic hepatitis C | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 12 | 7 | |
2018 | Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV | CHUN-JEN LIU ; Chuang W.-L.; Sheen I.-S.; Wang H.-Y.; Chen C.-Y.; Tseng K.-C.; Chang T.-T.; Massetto B.; Yang J.C.; Yun C.; Knox S.J.; Osinusi A.; Camus G.; Jiang D.; Brainard D.M.; McHutchison J.G.; Hu T.-H.; Hsu Y.-C.; Lo G.-H.; Chu C.-J.; Chen J.-J.; Peng C.-Y.; Chien R.-N.; PEI-JER CHEN | Gastroenterology | 95 | 82 | |
2020 | Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis | CHEN-HUA LIU ; Peng C.-Y.; YU-JEN FANG ; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; TUNG-HUNG SU ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Scientific Reports | 8 | 6 | |
2005 | Electrical detection of DNA hybridization with multilayer gold nanoparticles between nanogap electrodes | Tsai C.-Y.; Tsai Y.-H.; Pun C.-C.; Chan B.; Luh T.-Y.; Chen C.-C.; Ko F.-H.; PEI-JER CHEN ; Chen P.-H. | Microsystem Technologies | 22 | 21 | |